Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges

被引：11
|
作者：
Blumer, Ian [1 ,2 ]
Clement, Maureen [3 ]
机构：
[1] Charles H Best Diabet Ctr, Ajax, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ British Columbia, Diabet Educ Ctr, Vernon, BC, Canada
来源：
CLINICAL THERAPEUTICS | 2017年 / 39卷 / 08期
关键词：
basal insulin; hypoglycemia; management; type; 2; diabetes; TO-TARGET TRIAL; PATIENT-REPORTED OUTCOMES; GLARGINE; 100; UNITS/ML; GLYCEMIC CONTROL; COGNITIVE FUNCTION; GLUCOSE CONTROL; NPH INSULIN; PEOPLE; DEGLUDEC; RISK;
D O I：
10.1016/j.clinthera.2016.09.020
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Hypoglycemia in people with insulin-treated type 2 diabetes can be a limiting factor for management and a barrier to optimizing glycemic control. Even mild episodes of hypoglycemia can affect an individual's quality of life, and fear of hypoglycemia can lead to underinsulinization. This article explores the prevalence and consequences of hypoglycemia in people with type 2 diabetes with a focus on those who use basal insulins, offering strategies for prevention and management. It also discusses the benefits and challenges associated with new basal insulins, and their potential role in reducing hypoglycemia risk. (C) 2017 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码：S1 / S11
页数：11
相关论文
共 50 条
  • [31] Change in plasma glucose following exercise in type 1 diabetes: a comparison of three basal insulins
    Arutchelvam, V.
    Heise, T.
    Dellweg, S.
    Elbroend, B.
    Minns, I.
    Home, P. D.
    DIABETOLOGIA, 2007, 50 : S24 - S24
  • [32] Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors
    Zhang, Tingting
    Ji, Linong
    Gao, Yan
    Zhang, Puhong
    Zhu, Dongshan
    Li, Xian
    Ji, Jiachao
    Zhao, Fang
    Zhang, Heng
    Guo, Xiaohui
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (11) : 675 - 684
  • [33] Hypoglycemia in People with Type 2 Diabetes and CKD
    Ahmad, Iram
    Zelnick, Leila R.
    Batacchi, Zona
    Robinson, Nicole
    Dighe, Ashveena
    Manski-Nankervis, Jo-Anne E.
    Furler, John
    O'Neal, David N.
    Little, Randie
    Trence, Dace
    Hirsch, Irl B.
    Bansal, Nisha
    de Boer, Ian H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (06): : 844 - 853
  • [34] Hypoglycemia in patients with type 2 diabetes mellitus
    Miller, CD
    Phillips, LS
    Ziemer, DC
    Gallina, DL
    Cook, CB
    El-Kebbi, IM
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (13) : 1653 - 1659
  • [35] TYPE 2 DIABETES PATIENT PERSPECTIVES ON HYPOGLYCEMIA
    Gwaltney, C.
    Martin, M. L.
    Gruenberger, J. B.
    VALUE IN HEALTH, 2010, 13 (07) : A297 - A297
  • [36] The Incidence and Costs of Hypoglycemia in Type 2 Diabetes
    Quilliam, Brian J.
    Simeone, Jason C.
    Ozbay, Burak
    Kogut, Stephen J.
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (10): : 673 - 680
  • [37] The burden of severe hypoglycemia in type 2 diabetes
    Liu, Jieruo
    Wang, Rosa
    Ganz, Michael L.
    Paprocki, Yurek
    Schneider, Doron
    Weatherall, James
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (01) : 179 - 186
  • [38] Hypoglycemia in type 2 diabetes: a critical review
    Murata, GH
    Duckworth, WC
    Hoffman, RM
    Wendel, CS
    Mohler, MJ
    Shah, JH
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (10) : 551 - 559
  • [39] Hypoglycemia, diabetes therapies and driving categories in type 2 diabetes
    Feher, Michael D.
    Langerman, Haya
    Evans, Marc
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (06) : 1005 - 1012
  • [40] Efficacy of Treatment with a Basal-Prandial Insulin Regimen in Patients with Type 2 Diabetes Mellitus Previously Treated with Premixed Insulins
    Garcia-Soidan, Francisco J.
    DIABETES, 2011, 60 : A605 - A606
12345